The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance
暂无分享，去创建一个
S. Hilsenbeck | R. Schiff | O. Delpuech | G. Chamness | C. Osborne | M. Pilling | C. Nagi | H. Weir | R. Jeselsohn | Xiaoyong Fu | J. Veeraraghavan | M. Shea | C. De Angelis | M. Rimawi | M. Trivedi | A. Nardone | M. Cataldo | Tamika Mitchell | Henry Brown